
Rivercell
Biotechnology and AI company building proprietary data infrastructure around how human cells respond to treatments and training a global cell model to predict these responses.
About
Rivercell is a Paris-based biotechnology and AI company that is building its own data infrastructure to understand how human cells respond to treatments. The company's proprietary platform generates large-scale, time-resolved, multimodal single-cell data, which is used to train its "AI Virtual Cell" (AIVC) model. This world model of the cell is designed to predict cellular responses in silico, aiming to accelerate and reshape the drug discovery process by reducing the need for extensive physical wet-lab experiments.
Key facts
At-a-glance profile data
- Website
- rivercell.ai
- Headquarters
- Paris, France
- Founded
- 2025
- Employees
- 10
- Total funding
- $25M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 7 Oct 2026 | Seed | $25M | HV Capital |
Tech stack
Detected on rivercell.ai, last scanned 18 Oct 2026. Run your own scan
- CDN
- Netlify
- Email provider
- Google Workspace
Frequently asked
Is Rivercell trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Rivercell is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Rivercell raised?
Rivercell has raised a total of $25M in funding. The most recent round on record is Seed.
How many employees does Rivercell have?
Rivercell has approximately 10 people on record.
